Replies to post #121227 on Biotech Values

[investorgold2002]

they are having active discussions so they can file for anchor indication with 25%-50% enrollment in CV outcomes in trial

this is mentioned around 16 mins in the Q&A section of call

http://www.investorcalendar.com/IC/CEPage.asp?ID=164219